Ondansetron Tablet, Film Coated
Product Images NDC 63850-0003

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 63850-0003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

8 mg Container Label (8mglabel)

Ondansetron Tablets USP 8 mg film-coated oral tablets label. The label shows the strength 8 mg, quantity of 30 tablets, and Rx only status. It is manufactured by Natco Pharma Limited with address in Kothur, India. The label includes storage instructions, barcode, and mentions the dosage form as film-coated tablets.*

FDA Label Image

Ondan4mg30packlabel (Ondan4mglabel)

Ondansetron Tablets, USP 4 mg film-coated tablets label. The label states each tablet contains 5 mg ondansetron hydrochloride dihydrate equivalent to 4 mg ondansetron. Pack size is 30 tablets. Manufactured by Natco Pharma Limited, Kothur, Andhra Pradesh, India. Includes storage instructions and a barcode.*

FDA Label Image

Ondansetron Structure (Structure1)

Chemical structure diagram of Ondansetron hydrochloride dihydrate, showing its molecular arrangement with ring structures, nitrogen atoms, and a hydrate component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.